Kairos Pharma, LTD.
KAPA- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001962011
No open-market purchases or sales by Kairos Pharma, LTD. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $371.1K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +3 vs. previous quarter
- 14
- 13F valueReported value at the end of Q2 2026
- $371.1K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding KAPA, Q2 2026
No superinvestor reported holding KAPA at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Kairos Pharma, LTD. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2024 (view filing) | Nov 25 | Same day | Murali RamachandranVP of Research and Development | PPurchase | +200 | $1.59 | +$318 | +0.2%133.1K after | |
| Nov 25, 2024 (view filing) | Nov 22 | 3 days | Samuelson DougChief Financial Officer | PPurchase | +2.50K | $1.50 | +$3.75K | +4.3%60.8K after | |
| Nov 21, 2024 (view filing) | Nov 20 | 1 day | Yu John SCEO and Chairman | PPurchase | +4.00K | $1.44 | +$5.76K | +0.1%5.34M after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Kairos Pharma, LTD. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 309,834 | $118.9K | 0.00% | +309,834 | New |
| Vanguard Capital Management LLC | 231,878 | $89.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 82,092 | $31.0K | 0.00% | +82,092 | New |
| Geode Capital Management, LLC | 78,924 | $30.3K | 0.00% | −32,366−29.1% | Reduced |
| Vanguard Fiduciary Trust Co | 63,884 | $24.5K | 0.00% | 00.0% | Unchanged |
| SevenBridge Financial Group, LLC | 44,286 | $17.1K | 0.00% | 00.0% | Unchanged |
| Aptus Capital Advisors, LLC | 44,286 | $17.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 33,749 | $12.9K | 0.00% | +33,749 | New |
| Susquehanna International Group, LLP | 29,292 | $11.2K | 0.00% | +29,292 | New |
| State Street Corp | 24,100 | $9.25K | 0.00% | 00.0% | Unchanged |